pL-SFFV.Reporter.RFP657.PAC Citations (3)

Plasmid Article: Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing.
Heckl D, Kowalczyk MS, Yudovich D, Belizaire R, Puram RV, McConkey ME, Thielke A, Aster JC, Regev A, Ebert BL Nat Biotechnol. 2014 Jun 22. doi: 10.1038/nbt.2951. PubMed Journal

---

Articles Citing pL-SFFV.Reporter.RFP657.PAC

Articles
Multiplex CRISPR/Cas9-Based Genome Editing in Human Hematopoietic Stem Cells Models Clonal Hematopoiesis and Myeloid Neoplasia. Tothova Z, Krill-Burger JM, Popova KD, Landers CC, Sievers QL, Yudovich D, Belizaire R, Aster JC, Morgan EA, Tsherniak A, Ebert BL. Cell Stem Cell. 2017 Oct 5;21(4):547-555.e8. doi: 10.1016/j.stem.2017.07.015. PubMed
Caspase-1 initiates apoptosis in the absence of gasdermin D. Tsuchiya K, Nakajima S, Hosojima S, Thi Nguyen D, Hattori T, Manh Le T, Hori O, Mahib MR, Yamaguchi Y, Miura M, Kinoshita T, Kushiyama H, Sakurai M, Shiroishi T, Suda T. Nat Commun. 2019 May 7;10(1):2091. doi: 10.1038/s41467-019-09753-2. PubMed
High-throughput identification of autoantibodies that target the human exoproteome. Wang EY, Dai Y, Rosen CE, Schmitt MM, Dong MX, Ferre EMN, Liu F, Yang Y, Gonzalez-Hernandez JA, Meffre E, Hinchcliff M, Koumpouras F, Lionakis MS, Ring AM. Cell Rep Methods. 2022 Feb 28;2(2). doi: 10.1016/j.crmeth.2022.100172. Epub 2022 Feb 17. PubMed

If you have published an article using this plasmid, please email us at to have your article added to this page.